Literature DB >> 10325266

Laparoscopic tubal anastomosis and reversal of sterilization.

P J Barjot1, G Marie, P Von Theobald.   

Abstract

Fallopian tube interruption is a common form of contraception worldwide. For a variety of reasons (e.g. change in marital status, wish for additional children, psychological factors), many of these women seek restoration of fertility. Laparoscopic tubal anastomosis is one of the newest of these procedures by which this can be achieved. Sixteen women underwent laparoscopic microsurgical anastomosis. We used a three-stitches technique with tubal cannulation adapted from methods described in the literature. Five pregnancies occurred, giving an overall pregnancy rate of 31.2%. Surgical outcome depends on the patient's age, the method of tube interruption and the length of Fallopian tube segments being anastomosed. In this study, the feasibility of laparoscopic tubal sterilization reversal is confirmed, as well as the benefits offered by laparoscopic procedures in terms of quality of life. Further improvement of surgical outcome will be achieved not only through better laparoscopic techniques but also through careful screening for surgical indications.

Entities:  

Keywords:  Americas; Clinical Research; Developed Countries; Endoscopy; Examinations And Diagnoses; Family Planning; Female Sterilization; Laparoscopy; North America; Northern America; Physical Examinations And Diagnoses; Research Methodology; Research Report; Reversible Sterilization; Sterilization Reversal; Sterilization, Sexual; Tubal Ligation; Tubal Occlusion; United States

Mesh:

Year:  1999        PMID: 10325266     DOI: 10.1093/humrep/14.5.1222

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  2 in total

1.  Robotic applications in reproductive endocrinology and infertility.

Authors:  Julie Sroga; Sejal Dharia Patel
Journal:  J Robot Surg       Date:  2008-02-28

2.  Robotic tubal anastomosis: technical aspects.

Authors:  Mohamed A Bedaiwy; Ehab M Barakat; Tommaso Falcone
Journal:  JSLS       Date:  2011 Jan-Mar       Impact factor: 2.172

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.